ENTPD1 and tuberculosis: Collectively, these findings positioned CD39 as a critical regulator of immune exhaustion and dysregulation in TB, with age-dependent effects, and a potential biomarker and therapeutic target for reversing immune dysfunction and enhancing antimicrobial immunity in fighting against TB.